Combination vaccines give you an important option
Discuss the possible use of combination vaccines with your child's doctor. Talking with your child's doctor about your child's health, development and immunizations is the key to building a strong relationship.
Next time you see your child's doctor, ask these questions:
- What diseases will these vaccinations prevent?
- How will my child feel after the vaccination? What can I do to help my child?
- Which vaccinations will my child have at the next visit?
- Is there a combination vaccine that can help reduce the number of shots my child gets at each visit?
- Are any of these immunizations required for kindergarten?
Are combination vaccines recommended?
Yes. The American Academy of Pediatrics, the American Academy of Family Physicians, and the Advisory Committee on Immunization Practices (ACIP) all prefer combination vaccines as a way to minimize the number of shots children receive at a single doctor visit and improve the chances for your child receiving his or her shots on time.
Make the most of your time at your child's checkups. Plan ahead by doing the following:
- Write down any concerns. Bring the list with you to the visit.
- Be prepared for possible waits. Bring activities for your child during this wait.
- Know the office routine. Arrive early to complete paperwork.
- Remind yourself that vaccinating your child is one of the best things you can do for his or her health.
- Be well informed about immunization choices.
- Be an active partner with your child's doctors.
NEXT: Learn more about the diseases that KINRIX can protect your child against.
Ask your doctor if KINRIX is right for your child.
KINRIX is indicated for the fifth DTaP and fourth dose IPV in 4 to 6 year olds whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX.
Important Safety Information
In clinical studies, common adverse events were injection-site reactions (pain, redness, swelling, or increase in arm circumference), drowsiness, fever, and loss of appetite. Previous hypersensitivity to any component of KINRIX, including neomycin and polymyxin B, is a contraindication. Encephalopathy within 7 days of administration of a previous pertussis-containing vaccine or a progressive neurologic disorder is a contraindication. The decision to give KINRIX should be based on potential benefits and risks, if Guillain-Barré syndrome has occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid, or if adverse events have occurred in temporal relation to receipt of a pertussis-containing vaccine. The needleless, prefilled syringes contain dry natural latex rubber and may cause allergic reactions. For children at higher risk for seizures, an antipyretic may be administered at the time of vaccination. Vaccination with KINRIX may not protect all individuals who received the vaccine.
Download the Complete Prescribing Information for KINRIX
Download Patient Information for KINRIX
Infanrix® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)
Pediarix® [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]
KINRIX is a trademark of GlaxoSmithKline.
Manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium
Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709
